HARBOR IP IS THE KEY TO
SEQUENCE LISTING COMPLIANCE
Finding the right key can be time consuming, costly and challenging.
For over 25 years, Harbor IP has helped clients navigate Sequence Listing compliance. Put our expertise to work for you and experience the Harbor IP difference as our industry transitions to WIPO Standard ST.26.
Harbor IP is the premiere outsource provider to Law Firm and Pharma Company’s IP Counsel for meeting US (37 CFR §§1.821-.825) as well as EP, PCT, and foreign Sequence Listing requirements under current WIPO Standard ST.25 and future WIPO Standard ST.26.
WE ARE READY FOR ST.26, ARE YOU?
Harbor IP has been anticipating this moment for a long time, ever since it was introduced over 10 years ago. Our active involvement with WIPO and years of experience working with various Patent Offices puts us in a very strong position for this change. Our Team is ready, how can we help?
WHY HARBOR IP
Because we believe in doing things right the first time and we guarantee our work. By working directly with our seasoned team members, you’ll have first-hand access to our deep knowledge of Sequence Listing requirements and Prior Art Searching.
We offer unmatched experience, depth of knowledge, and positive customer experience. We take the unknown out of navigating Sequence Listing preparation and give you the confidence that you’re in great hands.
PRIOR ART SEARCH
Leading law firms and companies utilize Harbor's expertise in the life sciences arena to perform biosequence, chemical structure, and full text searches for a variety of purposes.